G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models
Filipa Moreira‐Silva(Instituto Português de Oncologia Francisco Gentil), Cármen Jerónimo(Universidade do Porto), Vítor M. Gaspar(University of Aveiro), Margareta P. Correia(Universidade do Porto), Xabier Agirre(Universidad de Navarra), João F. Mano(University of Aveiro), Rui Henrique(Universidade do Porto), Antonio Pineda‐Lucena(Instituto de Investigación Sanitaria La Fe), Rita de Cássia Avellaneda Guimarães(Universidade Federal de Mato Grosso do Sul), João Lobo(Universidade do Porto), Gonçalo Outeiro-Pinho(Instituto Português de Oncologia Francisco Gentil), Jesús M. Paramio(Universidad Complutense de Madrid), Felipe Prósper(Institute of Human Genetics)
Cited by 17
Related Papers
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
|Cell|2020|2.3k
A DNA methylation fingerprint of 1628 human samples
|Genome Research|2011|418
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation
|Cell Metabolism|2020|178
Integrative epigenetic taxonomy of primary prostate cancer
|Nature Communications|2018|167